Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway
D. Gaiotti et al., Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway, MOL CARCINO, 27(2), 2000, pp. 97-109
Tumor necrosis factor-alpha (TNF-alpha) inhibits growth of normal cervical
keratinocytes but stimulates proliferation of human papillomavirus (HPV)-im
mortalized and cervical carcinoma-derived cell lines when mitogens such as
epidermal growth factor (EGF) or serum are depleted. Current work identifie
s the mechanism of growth stimulation. TNF-alpha promoted cell cycle progre
ssion by increasing expression of HPV-16 E6/E7 RNA5 and enhancing activity
of cyclin-dependent kinase (cdk)2 and cdc2 after 3 d. Increased kinase acti
vity was mediated by upregulation of cyclins A and B and decreases in cdk i
nhibitors p21(Waf) and p27(kip). TNF-alpha stimulated these changes in part
by increasing transcription and stabilization of RNA for amphiregulin, an
EGF receptor ligand, and amphiregulin directly increased HPV-16 E6/E7 and c
yclin A RNAs. To define which components of the EGF receptor signaling path
way were important, HPV-immortalized cells were transfected with activated
or dominant negative mutants of Ha-ras, raf, or MAPKK. Expression of activa
ted Ha-ras maintained HPV-16 and cyclin gene expression and promoted rapid
growth in the absence of EGF. Furthermore, ras activation was necessary for
TNF-alpha mitogenesis as transfection with a dominant negative ras mutant
(Asn-17) strongly inhibited growth. Thus, activation of ras promotes expres
sion of HPV-16 E6/E7 RNAs, induces cyclins A and B, and mediates growth sti
mulation of immortal keratinocytes by TNF-alpha. These studies define a pat
hway by which ras mutations, which occur in a subset of cervical cancers, m
ay contribute to pathogenesis. Published by Wiley-Liss, Inc.